Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
Yükleniyor...
Tarih
2016
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Turkish Ophthalmological Soc
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Macular edema (ME) in retinitis pigmentosa (RP) often impairs central vision dramatically. A 41-year-old woman diagnosed with RP was referred to our outpatient clinic due to severe visual deterioration in both eyes. The patient was treated with topical carbonic anhydrase inhibitors, topical corticosteroids and intravitreal triamcinolone acetonide injections, but her ME recurred. Intravitreal 0.7 mg dexamethasone implant (Ozurdex, Allergan) was administered into both eyes without complications. On the fourth day after both injections, visual acuity improved and ME almost totally resolved. No recurrence was observed at follow-up six months later.
Açıklama
Ornek, Nurgul/0000-0003-3068-1831
Anahtar Kelimeler
Macular edema, retinitis pigmentosa, dexamethasone implant
Kaynak
Turk Oftalmoloji Dergisi-Turkish Journal Of Ophthalmology
WoS Q Değeri
N/A
Scopus Q Değeri
N/A
Cilt
46
Sayı
4
Künye
Örnek N., Örnek K., Erbahçeci İ. E. (2016). Retinitis Pigmentozaya İkincil İnatçı Maküla Ödeminde Deksametazon İntravitreal İmplant (Ozurdex). Türk Oftalmoloji Dergisi, 46(4), 179 - 181.
